• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型亚结构筛选器,可用于从筛选库中去除泛分析干扰化合物(PAINS),并在生物测定中对其进行排除。

New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

机构信息

The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade, Parkville, Victoria 3052, Australia.

出版信息

J Med Chem. 2010 Apr 8;53(7):2719-40. doi: 10.1021/jm901137j.

DOI:10.1021/jm901137j
PMID:20131845
Abstract

This report describes a number of substructural features which can help to identify compounds that appear as frequent hitters (promiscuous compounds) in many biochemical high throughput screens. The compounds identified by such substructural features are not recognized by filters commonly used to identify reactive compounds. Even though these substructural features were identified using only one assay detection technology, such compounds have been reported to be active from many different assays. In fact, these compounds are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.

摘要

本报告描述了一些亚结构特征,这些特征可以帮助识别在许多生化高通量筛选中频繁出现的化合物(混杂化合物)。通过这种亚结构特征识别出的化合物不能被通常用于识别反应性化合物的过滤器所识别。尽管这些亚结构特征仅使用一种检测技术进行了鉴定,但已有报道称这些化合物在许多不同的检测中都具有活性。事实上,这些化合物在文献中作为进一步探索的潜在起点越来越普遍,但实际上可能并非如此。

相似文献

1
New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.新型亚结构筛选器,可用于从筛选库中去除泛分析干扰化合物(PAINS),并在生物测定中对其进行排除。
J Med Chem. 2010 Apr 8;53(7):2719-40. doi: 10.1021/jm901137j.
2
Modeling Small-Molecule Reactivity Identifies Promiscuous Bioactive Compounds.小分子反应性建模鉴定广谱生物活性化合物。
J Chem Inf Model. 2018 Aug 27;58(8):1483-1500. doi: 10.1021/acs.jcim.8b00104. Epub 2018 Jul 23.
3
A high-throughput screen to identify novel calcineurin inhibitors.高通量筛选鉴定新型钙调神经磷酸酶抑制剂。
J Microbiol Methods. 2012 Jan;88(1):63-6. doi: 10.1016/j.mimet.2011.10.012. Epub 2011 Oct 26.
4
High-throughput assays for promiscuous inhibitors.针对多靶点抑制剂的高通量检测方法。
Nat Chem Biol. 2005 Aug;1(3):146-8. doi: 10.1038/nchembio718. Epub 2005 Jul 3.
5
Efficient hit-finding approaches for histone methyltransferases: the key parameters.组蛋白甲基转移酶的高效命中发现方法:关键参数
J Biomol Screen. 2012 Jan;17(1):85-98. doi: 10.1177/1087057111422823. Epub 2011 Oct 11.
6
Scopy: an integrated negative design python library for desirable HTS/VS database design.Scopy:一个集成的负设计 Python 库,用于设计理想的高通量筛选/虚拟筛选数据库。
Brief Bioinform. 2021 May 20;22(3). doi: 10.1093/bib/bbaa194.
7
Benchmarking the mechanisms of frequent hitters: limitation of PAINS alerts.频繁命中药物靶点的机制基准测试:PAINS 警报的局限性。
Drug Discov Today. 2021 Jun;26(6):1353-1358. doi: 10.1016/j.drudis.2021.02.003. Epub 2021 Feb 10.
8
Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery.哺乳动物细胞的遗传干预;在高通量筛选和药物发现中的应用和用途。
Cell Biol Toxicol. 2010 Feb;26(1):43-55. doi: 10.1007/s10565-009-9140-z. Epub 2009 Nov 11.
9
HTS promiscuity analyses for accelerating decision making.用于加速决策的高通量筛选混杂性分析
J Biomol Screen. 2011 Aug;16(7):765-74. doi: 10.1177/1087057111407763. Epub 2011 Jun 16.
10
Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.新型胃蛋白酶抑制剂的设计:基于EGEE网格的虚拟高通量筛选方法
J Chem Inf Model. 2007 Sep-Oct;47(5):1818-28. doi: 10.1021/ci600451t. Epub 2007 Aug 30.

引用本文的文献

1
Parallel synthesis of 5'-amino-5'-deoxy-adenosine derivatives for focused chemical space exploration and their application as methyltransferase inhibitors.用于聚焦化学空间探索的5'-氨基-5'-脱氧腺苷衍生物的平行合成及其作为甲基转移酶抑制剂的应用。
RSC Med Chem. 2025 Aug 12. doi: 10.1039/d5md00376h.
2
MolMod: a molecular modification platform for molecular property optimization via fragment-based generation.MolMod:一个通过基于片段生成来优化分子性质的分子修饰平台。
Mol Divers. 2025 Sep 4. doi: 10.1007/s11030-025-11342-z.
3
ADMET-Guided Docking and GROMACS Molecular Dynamics of Phytochemicals Uncover Mutation-Agnostic Allosteric Stabilisers of the KRAS Switch-I/II Groove.
基于ADMET的植物化学物质对接及GROMACS分子动力学研究揭示KRAS开关I/II结构域凹槽的非突变型别别构稳定剂
Pharmaceuticals (Basel). 2025 Jul 25;18(8):1110. doi: 10.3390/ph18081110.
4
Drug Repurposing for Kala-Azar.用于治疗黑热病的药物重新利用
Pharmaceutics. 2025 Aug 6;17(8):1021. doi: 10.3390/pharmaceutics17081021.
5
Synergistic targeting of cancer-related proteins by benzyl isothiocyanate and caffeic acid: MLSD and cytotoxic mechanisms in MCF-7 cells.异硫氰酸苄酯和咖啡酸对癌症相关蛋白的协同靶向作用:MCF-7细胞中的MLSD及细胞毒性机制
3 Biotech. 2025 Sep;15(9):291. doi: 10.1007/s13205-025-04469-1. Epub 2025 Aug 11.
6
Identification of natural products and synthetic analogs which inhibit microsporidia spores and prevent infection.鉴定能够抑制微孢子虫孢子并预防感染的天然产物和合成类似物。
bioRxiv. 2025 Aug 6:2025.08.06.669004. doi: 10.1101/2025.08.06.669004.
7
Penicillium-Derived Inhibitors of Lactate Dehydrogenase (PfLDH): A Computational Approach for Novel Antimalarial Therapy Development.青霉来源的乳酸脱氢酶抑制剂(PfLDH):新型抗疟治疗药物研发的计算方法
Scientifica (Cairo). 2025 Aug 4;2025:8838031. doi: 10.1155/sci5/8838031. eCollection 2025.
8
Discovery of a novel RSK2 inhibitor for the treatment of metastatic pancreatic cancer.发现一种用于治疗转移性胰腺癌的新型RSK2抑制剂。
J Enzyme Inhib Med Chem. 2025 Dec;40(1):2538673. doi: 10.1080/14756366.2025.2538673. Epub 2025 Aug 5.
9
STELLA provides a drug design framework enabling extensive fragment-level chemical space exploration and balanced multi-parameter optimization.STELLA提供了一个药物设计框架,能够进行广泛的片段级化学空间探索和平衡的多参数优化。
Sci Rep. 2025 Aug 1;15(1):28135. doi: 10.1038/s41598-025-12685-1.
10
Design, synthesis, crystal structure of novel hydrazone analogues as SARS-CoV-2 potent inhibitors: MD simulations, MM-GBSA, docking and ADMET studies.新型腙类似物作为SARS-CoV-2有效抑制剂的设计、合成、晶体结构:分子动力学模拟、MM-GBSA、对接及ADMET研究
R Soc Open Sci. 2025 Jul 9;12(7). doi: 10.1098/rsos.250373. eCollection 2025 Jul.